JOHNSON & JOHNSON is 312.1x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($573.98 B vs $1.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIP | JNJ |
|---|---|---|
| Market cap | $1.84 B | $573.98 B |
| US-listed rank | #2158 | #20 |
| Revenue (latest FY) | $883.37M | $94.19B |
| Net income (latest FY) | $78.00M | $26.80B |
| Net margin | 8.8% | 28.5% |
| P/E (trailing FY) | 23.6 | 21.4 |
| SEC filings | 1,742 | 984 |
JOHNSON & JOHNSON is 312.1x more valuable than ANI PHARMACEUTICALS INC by market capitalization ($573.98 B vs $1.84 B).
In their latest fiscal years, ANI PHARMACEUTICALS INC reported $883.37M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: ANI PHARMACEUTICALS INC and JOHNSON & JOHNSON, or browse the full rankings.